Can H. pylori cause chronic gastritis and alter acid secretion while low-level PCR remains weak evidence of active infection?

Pathological mechanisms of H. pylori

• Gastric inflammation: Helicobacter pylori colonization triggers mucosal inflammation, generating pro-inflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-alpha (TNF-α). This sustained inflammatory state drives progressive tissue injury, gland remodeling, and parietal cell apoptosis, defining chronic atrophic gastritis.
• Parietal-cell dysfunction: The bacteria alter acid secretion through direct and indirect pathways. Directly, H. pylori represses the H+/K+-ATPase (proton pump) α-subunit via integrin-mediated EGFR/ERK/NF-κB signaling. Indirectly, elevated IL-1β and TNF-α directly inhibit parietal cell activity, while neuroendocrine pathways involving CGRP-sensory neurons stimulate somatostatin release to suppress parietal activation, ultimately altering gastric acid secretion.

Diagnostic utility of PCR thresholds

• Clinical vs. analytical sensitivity: PCR assays are highly sensitive near their analytical limits, but low-level detection below clinically validated reference thresholds—which are optimized using receiver operating characteristic (ROC) curves against culture or histology—is not strongly associated with active clinical infection.
• Interpretation of low-level DNA: Signals below clinical cutoffs frequently reflect asymptomatic colonization, transient or nonviable DNA, or background noise. While low-level DNA can occasionally indicate an occult or PPI-suppressed infection, diagnosing an active infection based solely on weak PCR signals without concordant clinical or histological support is not justified.

Bottom line

• H. pylori drives chronic gastritis and alters acid secretion through cytokine-mediated parietal-cell inhibition and direct EGFR/ERK/NF-κB pathway suppression. However, low-level PCR detection below established clinical thresholds lacks diagnostic specificity and typically represents colonization or transient DNA rather than active, pathogenic infection.